Results 141 to 150 of about 31,479 (242)

Elimination of Onchocerca volvulus Transmission in the Huehuetenango Focus of Guatemala

Journal of Parasitology Research, 2012
In Latin America, onchocerciasis is targeted for elimination by 2012 through twice-yearly mass treatment of the eligible population with ivermectin.
Nancy Cruz-Ortiz, Rodrigo J. Gonzalez, Kim A. Lindblade, Frank O. Richards, Mauricio Sauerbrey, Guillermo Zea-Flores, Alfredo Dominguez, Orlando Oliva, Eduardo Catú, Nidia Rizzo   +9 more
doaj   +1 more source

Use of theLitomosoides sigmodontis- Mouse model in development of anOnchocercavaccine. I - molecular ofO. volvulusantigens [PDF]

, 1994
David W. Taylor, Gabriele Braun, Fred Engelbrecht, Graciela Salinas, Katharine A. Sinha   +4 more
openalex   +1 more source

Ivermectin for onchocercal eye disease (river blindness).

, 2012
BACKGROUND: It is believed that ivermectin (a microfilaricide) could prevent blindness due to onchocerciasis. However, when given to everyone in communities where onchocerciasis is common, the effects of ivermectin on lesions affecting the eye are ...
Ejere, Henry OD, Evans, Jennifer R, Schwartz, Ellen, Wormald, Richard   +3 more
core   +1 more source

Beyond Tradition: Exploring Cutting-Edge Approaches for Accurate Diagnosis of Human Filariasis

Pathogens
Filariasis is recognised as a global public health threat, particularly in tropical and subtropical regions. It is caused by infection with a nematode parasite of the superfamily Filarioidea, including Wuchereria bancrofti, Brugia malayi, Onchocerca ...
Damian Pietrzak, Julia Weronika Łuczak, Marcin Wiśniewski   +2 more
doaj   +1 more source

An empirical method to estimate the effect of soil on the rate for transmission of damping‐off disease

, 2004
The ability of some soils to suppress soil-borne diseases has been long recognised, but the underlying epidemiological mechanisms by which this occurs are largely unknown.• Using damping-off disease caused by Rhizoctonia solani, spreading through ...
Alabouvette C, Bailey DJ, C. A. Gilligan, Cook RJ, Dwyer G, Garrett KA, Gilligan CA, Gilligan CA, Gilligan CA, Hoper H, J. A. N. Filipe, Jeger MJ, Kleczkowski A, Nisbet RM, Otten W, Pielaat A, van den Bosch F, Van der Plank JE, W. Otten, Whipps JM   +19 more
core   +1 more source

Reproductive biology and population dynamics ofOnchocerca volvulusin the vertebrate host [PDF]

, 1994
H. Schulz‐Key, Peter T. Soboslay
openalex   +1 more source

Epitopes of the Onchocerca volvulus RAL1 antigen, a member of the calreticulin family of proteins, recognized by sera from patients with onchocerciasis [PDF]

, 1994
Luis A. Rokeach, Peter A. Zimmerman, Thomas R. Unnasch   +2 more
openalex   +1 more source

Drugs that target early stages of Onchocerca volvulus: A revisited means to facilitate the elimination goals for onchocerciasis

, 2021
S Jawahar, Nancy Tricoche, Christina A. Bulman, Judy A. Sakanari, Sara Lustigman   +4 more
openalex   +2 more sources

Epilepsy and nodding syndrome in association with an Onchocerca volvulus infection drive distinct immune profile patterns. [PDF]

PLoS Negl Trop Dis, 2023
Arndts K, Kegele J, Massarani AS, Ritter M, Wagner T, Pfarr K, Lämmer C, Dörmann P, Peisker H, Menche D, Al-Bahra M, Prazeres da Costa C, Schmutzhard E, Matuja W, Hoerauf A, Layland-Heni LE, Winkler AS.   +16 more
europepmc   +1 more source

ePresentations

European Journal of Neurology, Volume 31, Issue S1, June 2024.
wiley   +1 more source